Cadila Pharmaceuticals organises innovation conclave IAMICON 2014

The conclave will focus on advances in the treatment of tuberculosis and cardiovascular diseases

Ahmedabad based privately held drug major Cadila Pharmaceuticals Ltd is organising a major scientific conclave under the brand IAMICON 2014, that would be organised across 49 cities in the country from November 14 to 16 and November 21 to 23.

IAMICON 2014 (Indravadan Ambalal Modi Innovation Conclave) will focus on advances in the treatment of tuberculosis and cardiovascular diseases.

Cadila Pharmaceuticals is committed to the Union government's TB Mission 2020, which seeks to eliminate tuberculosis from the country. Close to 300 speakers and nearly 20,000 doctors, academicians and industry experts are expected to participate.